JPWO2022058745A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022058745A5 JPWO2022058745A5 JP2023518337A JP2023518337A JPWO2022058745A5 JP WO2022058745 A5 JPWO2022058745 A5 JP WO2022058745A5 JP 2023518337 A JP2023518337 A JP 2023518337A JP 2023518337 A JP2023518337 A JP 2023518337A JP WO2022058745 A5 JPWO2022058745 A5 JP WO2022058745A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridin
- carboxamide
- group
- imidazo
- propan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2014736.9A GB202014736D0 (en) | 2020-09-18 | 2020-09-18 | Novel compounds and their use in therapy |
| GB2014736.9 | 2020-09-18 | ||
| PCT/GB2021/052425 WO2022058745A2 (en) | 2020-09-18 | 2021-09-17 | Novel compounds and their use in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542203A JP2023542203A (ja) | 2023-10-05 |
| JPWO2022058745A5 true JPWO2022058745A5 (enExample) | 2024-10-08 |
Family
ID=73196866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518337A Pending JP2023542203A (ja) | 2020-09-18 | 2021-09-17 | イミダゾ［１，２－ａ］ピリジン化合物及び治療法におけるその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240166643A1 (enExample) |
| EP (1) | EP4214205A2 (enExample) |
| JP (1) | JP2023542203A (enExample) |
| KR (1) | KR20230069929A (enExample) |
| CN (1) | CN116157122B (enExample) |
| CA (1) | CA3195054A1 (enExample) |
| GB (1) | GB202014736D0 (enExample) |
| WO (1) | WO2022058745A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022082306A1 (en) * | 2020-10-20 | 2022-04-28 | Pacylex Pharmaceuticals Inc. | Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders |
| TW202421120A (zh) | 2022-09-09 | 2024-06-01 | 英商邁瑞科艾克斯醫藥有限公司 | 新穎化合物及其等於治療上之用途 |
| WO2025078841A2 (en) | 2023-10-11 | 2025-04-17 | Antikor Biopharma Limited | Antibodies, conjugates, and uses thereof |
| GB202403391D0 (en) | 2024-03-08 | 2024-04-24 | Myricx Pharma Ltd | Novel compounds and their use in therapy |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3763156A (en) * | 1970-01-28 | 1973-10-02 | Boehringer Sohn Ingelheim | 2-heterocyclic amino-4-morpholinothieno(3,2-d)pyrimidines |
| US3939268A (en) * | 1971-04-10 | 1976-02-17 | Boehringer Ingelheim Gmbh | 2,4-Diamino substituted pyridol(3,2-d)pyrimidine as antithrombotic agents |
| US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
| WO2000037464A2 (en) | 1998-12-18 | 2000-06-29 | Basilea Pharmaceutica Ag | 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| EP1697375A2 (en) * | 2003-12-02 | 2006-09-06 | Vertex Pharmaceuticals Incorporated | Heterocyclic protein kinase inhibitors and uses thereof |
| GB0815947D0 (en) | 2008-09-02 | 2008-10-08 | Univ Dundee | Compounds |
| AU2012311698B2 (en) * | 2011-09-22 | 2017-06-22 | Merck Sharp & Dohme B.V. | N-piperidin-4-yl derivatives |
| GB201120993D0 (en) | 2011-12-06 | 2012-01-18 | Imp Innovations Ltd | Novel compounds and their use in therapy |
| US10220034B2 (en) * | 2013-10-18 | 2019-03-05 | Indiana University Research And Technology Corporation | Hepatitis B viral assembly effectors |
| US9611252B2 (en) * | 2013-12-30 | 2017-04-04 | Lifesci Pharmaceuticals, Inc. | Therapeutic inhibitory compounds |
| GB201511382D0 (en) * | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
| PL3325662T3 (pl) | 2015-07-17 | 2024-02-26 | Pacylex Pharmaceuticals Inc. | Wyciszenie epigenetyczne nmt2 |
| US10227329B2 (en) * | 2016-07-22 | 2019-03-12 | Blueprint Medicines Corporation | Compounds useful for treating disorders related to RET |
| GB201820659D0 (en) | 2018-12-19 | 2019-01-30 | Imperial Innovations Ltd | Novel compostions and their use in therapy |
| GB201820660D0 (en) | 2018-12-19 | 2019-01-30 | Imperial Innovations Ltd | Cancer treatments |
-
2020
- 2020-09-18 GB GBGB2014736.9A patent/GB202014736D0/en not_active Ceased
-
2021
- 2021-09-17 CA CA3195054A patent/CA3195054A1/en active Pending
- 2021-09-17 KR KR1020237008901A patent/KR20230069929A/ko active Pending
- 2021-09-17 EP EP21787011.2A patent/EP4214205A2/en active Pending
- 2021-09-17 US US18/026,684 patent/US20240166643A1/en active Pending
- 2021-09-17 JP JP2023518337A patent/JP2023542203A/ja active Pending
- 2021-09-17 CN CN202180063453.7A patent/CN116157122B/zh active Active
- 2021-09-17 WO PCT/GB2021/052425 patent/WO2022058745A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101588583B1 (ko) | 키나제 억제제로서의 이미다조트리아진 및 이미다조피리미딘 | |
| DK2017278T3 (en) | DIHYDROPYRAZOLOPYRIMIDINON DERIVATIVES | |
| AU2011274192B2 (en) | Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof | |
| AU2019323035B2 (en) | Pyrazine compounds and uses thereof | |
| CA3251001A1 (en) | QUINAZOLINE COMPOUNDS AND THEIR USE AS INHIBITORS OF MUTANT KRAS PROTEINS | |
| AU2009257434B2 (en) | Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptor | |
| AU2015243694B2 (en) | (5,6-dihydro)pyrimido(4,5-e)indolizines | |
| TW201803854A (zh) | 經胺取代之芳基或雜芳基化合物 | |
| WO2025000265A1 (en) | Heterocyclic compounds usefull as sos1 inhibitor | |
| KR20250121029A (ko) | 두드러기 치료를 위한 야생형 c-kit 키나제 억제제로서의 n-페닐-피라졸로[1,5-a]피리딘-3-카르복사미드 유도체 | |
| JP2025531794A (ja) | がんの治療のためのＦＧＦＲ３阻害剤としてのピラゾロ［１，５－ａ］ピリジン及びイミダゾ［１，２－ａ］ピリジン誘導体 | |
| JP2017526720A (ja) | キナーゼ阻害剤としての化合物および組成物 | |
| AU2021321536A1 (en) | Kinase inhibitors and uses thereof | |
| EP4267137A1 (en) | Lactam (hetero)arylfusedpyrimidine derivatives as inhibitors of erbb2 | |
| KR20220152508A (ko) | 헤테로아릴 유도체, 이를 제조하는 방법, 및 이를 유효성분으로 포함하는 약학적 조성물 | |
| CN117693503A (zh) | 作为hpk1抑制剂用于治疗癌症的经取代的吡嗪-2-甲酰胺 | |
| JP2023513333A (ja) | キノリニル基ホスフィンオキシド化合物、並びにその組成物及び使用 | |
| JP7681116B2 (ja) | カルボニル置換ジアザスピロ化合物及びその使用 | |
| JPWO2022058745A5 (enExample) | ||
| KR102603203B1 (ko) | 히스타민 h4-수용체 저해제로서 피리도피리미딘류 | |
| CN112279837B (zh) | 吡嗪化合物和其用途 | |
| JP2024528614A (ja) | ニトリルｓｕｍｏ阻害剤及びその使用 | |
| WO2025099451A1 (en) | New compounds and methods | |
| EA048652B1 (ru) | Ингибиторы sos1 | |
| HK40046541B (en) | Pyridopyrimidines as histamine h4-receptor inhibitors |